Skip to main content
. 2022 Aug 5;17(8):e0268712. doi: 10.1371/journal.pone.0268712

Table 5. The odds of death affected by immune cells in patients with COVID-19.

Immune cells Model 1 Model 2
OR (95% CI) P OR (95% CI) P
CD3+ 0.90 (0.74–1.00) 0.07 0.90 (0.74–1.10) 0.14
CD4+ 0.74 (0.61–0.90) 0.029 0.74 (0.61–0.90) 0.029
CD8+ 1.00 (0.82–1.22) 0.63 0.90 (0.74–1.10) 0.45
CD16+ 0.50 (0.27–0.90) 0.042 0.55 (0.30–0.99) 0.047
CD20+ 1.00 (0.67–1.49) 0.81 1.00 (067–1.49) 0.86
CD16+CD56+ 0.5 (0.12–2) 0.32 0.90 (0.15–2.44) 0.14

*unadjusted.

**adjusted for age, sex and comorbidity.